Biotech RadarJobs updated

COMPANY

Adiso Therapeutics

adisotx.com ↗

Clinical Phase 1

Keywords: respiratory inflammatory diseases Ulcerative Colitis Clostridium Difficile Infection Recurrence BT051 ART24

Profile checked Oct 10, 2026

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC) source ↗
  2. Trial start Phase 1: A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI) source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT05084261An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)Phase 1CompletedNov 30, 2021Nov 30, 2022 (actual)
NCT04891965A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)Phase 1CompletedFeb 27, 2020Jul 7, 2022 (actual)
Feedback